Literature DB >> 12122168

Visual association test to detect early dementia of the Alzheimer type.

J Lindeboom1, B Schmand, L Tulner, G Walstra, C Jonker.   

Abstract

BACKGROUND: The visual association test (VAT) is a brief learning task based on imagery mnemonics. The test materials consist of six line drawings of pairs of interacting objects or animals-for example, an ape holding an umbrella. The person is asked to name each object and, later, is presented with one object from the pair and asked to name the other.
OBJECTIVE: To verify that the task induces robust incidental or effortless learning (study 1), and to study the efficiency of the test as a discriminator between early dementia of the Alzheimer type (DAT) and non-demented people (study 2) and non-DAT types of dementia (study 3).
METHODS: Study 1: two groups of elderly volunteers were administered the VAT. The stimuli were presented in the interactive fashion to group A-for example, a monkey carrying an umbrella (n=83)-and side by side to group B-for example, separate pictures of a monkey alone and an umbrella alone (n=79). Group B received learning instructions, but group A did not. Study 2: three groups of subjects were selected from a population based follow up study: incident DAT cases (n=24), cognitively declining subjects not diagnosed with dementia (n=21), and stable non-demented subjects (n=204). Test performance of the non-demented group at baseline was compared with that of patients with DAT at the time of their diagnosis, of patients with DAT a year before their diagnosis, and of non-demented declining subjects at baseline. Study 3: subjects were patients referred for neuropsychological assessment because of suspected dementia. They were diagnosed by consensus criteria of various dementia syndromes.
RESULTS: Study 1: recall was more than twice as high in group A as in group B. Thus interactive presentation, even in the absence of learning instructions, enhances learning. Study 2: at a level of 97.5% specificity, the VAT had a sensitivity of 87.5% for DAT cases at the time of diagnosis and 66.7% one year before diagnosis. The cognitively declining group scored significantly lower on the VAT at baseline than the non-demented group. The VAT discriminated more effectively than both the MMSE and the six item picture learning task from the CAMCOG. Study 3: VAT scores were significantly lower in patients with DAT (n=48) than in patients with vascular dementia (n=37), frontotemporal dementia (n=9), or subcortical dementia (n=15), but not lower than in patients with Lewy body dementia (n=7). Mean mini mental state examination scores of these groups were not significantly different. The VAT discriminated patients with DAT from patients with other types of dementia more effectively than a prose recall test. Sensitivity was 79% and specificity 69%.
CONCLUSIONS: The VAT detects with high specificity a sizeable proportion of patients with DAT a year before the diagnosis, and a low VAT score is relatively uncommon in patients with non-DAT dementia.

Entities:  

Mesh:

Year:  2002        PMID: 12122168      PMCID: PMC1737993          DOI: 10.1136/jnnp.73.2.126

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  34 in total

1.  A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability.

Authors:  J R Copeland; M J Kelleher; J M Kellett; A J Gourlay; B J Gurland; J L Fleiss; L Sharpe
Journal:  Psychol Med       Date:  1976-08       Impact factor: 7.723

2.  Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  K A Welsh; N Butters; J P Hughes; R C Mohs; A Heyman
Journal:  Arch Neurol       Date:  1992-05

3.  Imagery as a mnemonic aid after left temporal lobectomy: contrast between material-specific and generalized memory disorders.

Authors:  M K Jones
Journal:  Neuropsychologia       Date:  1974-01       Impact factor: 3.139

4.  Memory coding and amnesia.

Authors:  A D Baddeley; E K Warrington
Journal:  Neuropsychologia       Date:  1973-05       Impact factor: 3.139

5.  A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT.

Authors:  J R Copeland; M E Dewey; H M Griffiths-Jones
Journal:  Psychol Med       Date:  1986-02       Impact factor: 7.723

Review 6.  'Subcortical dementia': the neuropsychological evidence.

Authors:  R G Brown; C D Marsden
Journal:  Neuroscience       Date:  1988-05       Impact factor: 3.590

7.  The ancient art of memory. Usefulness in treatment.

Authors:  B M Patten
Journal:  Arch Neurol       Date:  1972-01

8.  CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

Authors:  M Roth; E Tym; C Q Mountjoy; F A Huppert; H Hendrie; S Verma; R Goddard
Journal:  Br J Psychiatry       Date:  1986-12       Impact factor: 9.319

9.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 10.  Subcortical dementia. Review of an emerging concept.

Authors:  J L Cummings; D F Benson
Journal:  Arch Neurol       Date:  1984-08
View more
  81 in total

1.  The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia.

Authors:  E F J Meulen; B Schmand; J P van Campen; S J de Koning; R W Ponds; P Scheltens; F R Verhey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

2.  A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.

Authors:  Anna C van Loenhoud; Alle Meije Wink; Colin Groot; Sander C J Verfaillie; Jos Twisk; Frederik Barkhof; Bart van Berckel; Philip Scheltens; Wiesje M van der Flier; Rik Ossenkoppele
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

Review 3.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

4.  Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study.

Authors:  Giorgos Karas; Philip Scheltens; Serge Rombouts; Ronald van Schijndel; Martin Klein; Bethany Jones; Wiesje van der Flier; Hugo Vrenken; Frederik Barkhof
Journal:  Neuroradiology       Date:  2007-10-23       Impact factor: 2.804

5.  Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.

Authors:  Jirayu Tanprasertsuk; Elizabeth J Johnson; Mary Ann Johnson; Leonard W Poon; Peter T Nelson; Adam Davey; Peter Martin; Aron K Barbey; Kathryn Barger; Xiang-Dong Wang; Tammy M Scott
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease.

Authors:  Alice Jaillard; Matthieu Vanhoutte; Aurélien Maureille; Susanna Schraen; Emilie Skrobala; Xavier Delbeuck; Adeline Rollin-Sillaire; Florence Pasquier; Stéphanie Bombois; Franck Semah
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-28       Impact factor: 9.236

7.  Picture-based memory impairment screen for dementia.

Authors:  Joe Verghese; Mohan L Noone; Beena Johnson; Anne F Ambrose; Cuiling Wang; Herman Buschke; Vayyattu G Pradeep; Kizhakkaniyakath Abdul Salam; Kunnukatil S Shaji; Pavagada S Mathuranath
Journal:  J Am Geriatr Soc       Date:  2012-10-05       Impact factor: 5.562

8.  Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory.

Authors:  Kathryn V Papp; Rebecca E Amariglio; Maria Dekhtyar; Kamolika Roy; Sarah Wigman; Rose Bamfo; Julia Sherman; Reisa A Sperling; Dorene M Rentz
Journal:  Clin Neuropsychol       Date:  2014-05-12       Impact factor: 3.535

9.  Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.

Authors:  W J P Henneman; H Vrenken; J Barnes; I C Sluimer; N A Verwey; M A Blankenstein; M Klein; N C Fox; P Scheltens; F Barkhof; W M van der Flier
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

10.  Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial.

Authors:  Els I S Most; Philip Scheltens; Eus J W Van Someren
Journal:  Trials       Date:  2010-02-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.